Soleno Inc at the BIO CEO & Investor Conference - Soleno

Company
- Management
- Board
- Advisors
- Careers
Product Candidate
For Patients
- Prader-Willi Syndrome
- Patient Access
Investors
Contact us

News

Lorem ipsum dolor sit amet, maiorum oportere definitiones cu vel, ei his alii delenit sensibus, nec omnium nominavi consequat in. Mea hinc animal incorrupte ei, usu ne percipit disputationi.

Soleno Inc at the BIO CEO & Investor Conference

May 31, 2017 Soleno Inc at the BIO CEO & Investor Conference

Developing novel therapeutics for the treatment of rare diseases.

Pages

Company
- Management
- Boards
- Advisors
- Careers
For Patients
- Prader-Willi Syndrome
Investors
Contact us

News and Events

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome

Soleno Therapeutics Announces Financing Commitment for up to $60 Million

Contact Us

203 Redwood Shores Parkway
Suite 500
Redwood City, CA 94065

Tel: (650) 213-8444
Email: info@soleno.life
Find us on Facebook

Soleno Therapeutics, Inc. © 2023 | All Rights Reserved

Terms of Use
Privacy Statement